Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 482 of 5804
-
New hope for frail AML patients: less toxic drug combo shows promise
Disease control CompletedThis study aims to evaluate the efficacy and safety of selinexor-based chemotherapy-sparing regimens (including chemotherapy-free or dose-reduced approaches) in optimizing therapeutic strategies for treatment-naïve acute myeloid leukemia patients deemed unfit for intensive induct…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Kenya aims to slash HIV in Moms-to-Be with massive PrEP rollout
Prevention ENROLLING_BY_INVITATIONThis project aims to develop a community of practice; then test a combination of community of practice, quality improvement, and a training toolkit, to enhance implementation and clinical outcomes; and identify patterns attributes associated with successful implementation.
Phase: PHASE4 • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control Recruiting nowThis is a multicenter, open-label, non-randomized, multi-cohort study to evaluate the efficacy and safety of linperlisib combined with cyclophosphamide, prednisone, and thalidomide (CPT) regimen in the treatment of relapsed and/or refractory non-Hodgkin lymphoma.
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Stomach cancer trial combines chemo with Bacteria-Fighting treatment
Disease control Recruiting nowThis study focuses on patients with H. pylori-positive resectable locally advanced adenocarcinoma of the gastric and oesophagogastric junction. It evaluates the perioperative oxaliplatin with S-1 (SOX) combined H. pylori eradication versus oxaliplatin with S-1 in the management o…
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Heart rhythm fix may also repair leaky valve: scientists build prediction model
Knowledge-focused ENROLLING_BY_INVITATIONMitral Regurgitation (MR) is the most prevalent type of valvular heart disease in clinical practice, with an average prevalence of approximately 1% in populations with moderate-to-severe or worse MR, which increases significantly with age. Functional MR (FMR) is one subtype of MR…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New hope for bladder cancer patients who can't have standard chemo
Disease control Recruiting nowThis phase II trial tests how well the combination of futibatinib and durvalumab given before cystectomy works in treating patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based therapy. Cisplatin-based therapy is the standard of care for patie…
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a second chemo drug slow prostate cancer growth?
Disease control Recruiting nowThe usual approach for most patients who are not in a study is treatment with docetaxel. This study is being done to answer the following question: Can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual approach? This study is being done…
Phase: PHASE3 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Scientists create personalized antibodies to attack stage IV cancer
Disease control ENROLLING_BY_INVITATIONThe purpose of this research is to study the safety and effectiveness of investigational antibodies attacking certain areas on the surface of cancer cells so that the body can kill the cancer cells. The antibodies will be made in a laboratory from cells taken from each subject's …
Phase: PHASE1 • Sponsor: Moonshot Antibodies • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New injection could help shed pounds in obesity trial
Disease control OngoingThis is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study in adult obese/overweight subjects in China to evaluate the efficacy and safety of GZR18 Injection in the subjects.
Phase: PHASE3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for hepatitis b: Real-World trial of pradefovir underway
Disease control OngoingThis study is a multicenter, ambidirectional cohort real-world study initiated by the First Affiliated Hospital of Zhengzhou University, aiming to evaluate the efficacy and safety of Pradefovir Mesylate Tablets in the treatment of chronic hepatitis B (CHB).
Sponsor: Juan Li • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New targeted drug SYS6043 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowPhase I/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors This study is a first-in-human phase I/II, multicenter, open-label, dose-escalation trial with PK expansion and cohort expansion, designed to evaluate the safety, tolerability, pharmacokinet…
Phase: PHASE1, PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New triple therapy aims to shrink stomach tumors before surgery
Disease control Recruiting nowTo evaluate the initial efficacy and safety of neoadjuvant low-dose interval radiotherapy combined with tirelizumab and SOX chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma.
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New buccal film could lift depression when other drugs fail
Symptom relief Recruiting nowThis Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmucosal buccal film (VLS-01-BU) in patients with treatment resistant Major Depressive disorder (TRD) and will characterize the onset an…
Phase: PHASE2 • Sponsor: atai Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Virus injection targets pancreatic tumors in new trial
Disease control Recruiting nowThis is a single center, Phase I dose finding study of a single direct tumor injection of an RGD modified conditionally replicative adenovirus (RGDCRAdcox2F) in persons with adenocarcinoma of the pancreas. The study is designed to determine the MTD of RGDCRAdCOX2F that correspond…
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Pregnancy hepatitis b drug showdown: which is safer for mom and baby?
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn the efficacy and safety of Tenofovir alafenamide (TAF) vs Tenofovir disoproxil fumarate(TDF) in early and middle pregnancy antiviral therapy for chronic hepatitis B pregnant women. The main questions it aims to answer are: The rate of…
Phase: PHASE4 • Sponsor: The Third Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can less chemo be enough? new trial tailors treatment for early breast cancer
Disease control Recruiting nowTriple-negative breast cancer (TNBC) is a group of tumors that occurs mainly in young, premenopausal women and accounts for 10-20% of breast cancers. Over the past decade, the incidence of women diagnosed with early-stage TNBC has significantly increased due to the widespread use…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Nasal light zaps infection risk before surgery
Prevention CompletedThis is a Phase 3 multi-center, group-randomized, crossover trial to compare nasal antimicrobial photodisinfection therapy (aPDT) with standard of care for prevention of surgical site infections in patients undergoing major elective, urgent, or emergent surgeries in a hospital se…
Phase: PHASE3 • Sponsor: Ondine Biomedical Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Could a simple zinc pill save thousands of newborns from deadly infections?
Disease control Recruiting nowBacterial infections among young infants, including sepsis, meningitis, and pneumonia, continue to cause a substantial number of deaths globally. Zinc supplementation in combination with standard antibiotic therapy may represent a new intervention to reduce mortality and improve …
Phase: PHASE3 • Sponsor: Harvard School of Public Health (HSPH) • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Promising drug cocktail targets Hard-to-Treat ovarian cancer
Disease control OngoingThis single arm phase II study proposes to evaluate the efficacy and safety of nab-sirolimus + endocrine therapy (Fulvestrant) in patients with recurrent low grade serous ovarian cancer (LGSOC).
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Tiny radioactive spheres aim to destroy kidney tumors without surgery
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects and effectiveness of radioembolization with yttrium-90 (Y-90) in patients with early stage renal cell carcinoma. Y-90 is a radioactive chemical that is incorporated into millions of very tiny glass spheres. These spheres are in…
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC